The Conference on Retroviruses and Opportunistic Infections (CROI) in Seattle
The annual Conference on Retroviruses and Opportunistic Infections (CROI) is taking place in Seattle, Washington the week of February 23-26, 2015. Established in 1993, CROI brings together over 4,000 participants from around the globe to inform, discuss and brainstorm about current and future directions to prevent the morbidity and mortality from HIV.
Feb. 18, 2015 in VIDD News
Fred Hutchinson Cancer Research Center named a MIDAS Center of Excellence
Researchers at Fred Hutchinson Cancer Research Center, including several VIDD faculty, received a five-year, $12.5 million award from the National Institute of General Medical Sciences that designates the Seattle campus as a MIDAS Center of Excellence. Models of Infectious Disease Agency Study (MIDAS) centers are designated to play a role in planning for national emergencies such as a pandemic or an act of bioterrorism.
Sept. 23, 2014 in VIDD News
Nobel laureate Dr. Françoise Barré-Sinoussi, ‘the woman who discovered HIV,’ visits the Hutchinson Center
Françoise Barré-Sinoussi, PhD, who was awarded the 2008 Nobel Prize in Medicine for discovering HIV, will be the keynote speaker at the Conference on Cell and Gene Therapy for HIV Cure 2014 taking place August 26-27, 2014 at the Fred Hutchinson Cancer Research Center.
Aug. 21, 2014 in VIDD News
VIDD researchers receive $14.5M NIH grant for STI research
July 23, 2014 in VIDD News
CDC recommends daily pill for those at high risk for HIV
May 16, 2014 in VIDD News
VIDD Member Peter Gilbert receives ASA award
VIDD Member Dr. Peter Gilbert was selected as a Fellow of the American Statistical Association for his tremendous contribution to the field of biostatistics.
April 23, 2014 in VIDD News
Glenda Gray appointed new president of South African Medical Research Council
HIV expert Dr. Glenda Gray, VIDD member and co-principal investigator of the HIV Vaccine Trials Network (HVTN), has been named president of the South African Medical Research Council, the premier medical research organization and funder of medical research in South Africa.
March 24, 2014 in VIDD News
VIDD Welcomes Curt Malloy, new Division Administrator
VIDD would like to announce that Curt Malloy, JD, MPH will become the new VIDD Administrator effective February 17, 2014.
March 6, 2014 in VIDD News
VIDD Thanks Leslie Sandberg, outgiong Division Administrator
After nearly two years of dedicated service, Leslie Sandberg will, effective February 7th, be leaving VIDD to assume the Division Administrator role for the Center’s Clinical Research Division (CRD).
Feb. 6, 2014 in VIDD News
HIV Vaccine Trials Network among five nationwide selected to receive seven-year award
The HIV Vaccine Trials Network, part of the Vaccine and Infectious Disease Division, is among five clinical trial networks across the United States that will receive substantial federal funding to continue their work in the fight against HIV/AIDS.
Jan. 15, 2014 in VIDD News
South Africa Mourns Nelson Mandela's Death
Today the flags in South Africa fly at half-mast as we mourn the passing of the father of our nation. Nelson Mandela passed away last night at the age of 95, one of the icons of modern history, our own South African who became the face of freedom, not only for us, but for all the oppressed, the eternal symbol of freedom.
Dec. 6, 2013 in VIDD News
Fighting HIV on its Own Turf
Three years ago, VIDD scientists decided their best shot at developing an effective HIV vaccine was to try and beat the virus on its own turf, by launching clinical trials in a country that had lost an entire generation to AIDS: South Africa.
Oct. 21, 2013 in VIDD News
Genital Herpes-Suppressing Immune Cells Identified
Scientists at the Hutchinson Center Vaccine and Infectious Disease Division and University of Washington have identified a class of immune cells that reside long-term in the genital skin and mucosa and are believed to be responsible for suppressing recurring outbreaks of genital herpes.
May 8, 2013 in VIDD News
South African HVTN Researcher Receives Highest Civilian Award
HVTN investigator Dr. Glenda Gray, one of the world’s foremost authorities on the HIV epidemic in sub-Saharan Africa, is honored by South African President Jacob Zuma for her substantial achievements in designing, implementing and overseeing HIV vaccine trials, as well as ensuring those in most need of prevention and treatment measures benefit from advances made by the HIV/AIDS biomedical community.
May 8, 2013 in VIDD News
VIDD's Joshua Hill Wins Publication Prize
The Vaccine and Infectious Disease Division's Dr. Joshua Hill is the recipient of the Biology of Blood and Marrow Transplantation's 2012 George Santos Award for best clinical science article by a new investigator.
Feb. 19, 2013 in VIDD News
VIDD Plays Integral Role in Recent HIV Vaccine Breakthroughs
In 2009, the results of an HIV vaccine clinical trial sponsored by the Thai Ministry of Health and U.S. Military HIV Research Program galvanized the worldwide HIV vaccine community.
Oct. 22, 2012 in VIDD News
HPTN 052: Science Breakthrough of the Year, 2011
Every year, Science announces the Breakthrough of the Year, an honor bestowed to research that impacts a wide array of scientists and has far-reaching and profound implications.
Jan. 9, 2012 in VIDD News